We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.2B
AUM Growth
+$3.24B
(+7.1%)
Cap. Flow
+$512M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
15.87%
Holding
2,920
New
16
Increased
1,206
Reduced
1,586
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$23.3M |
| 2 |
Becton Dickinson
BDX
|
+$18.4M |
| 3 |
Amazon
AMZN
|
+$16.1M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$15.4M |
| 5 |
Johnson & Johnson
JNJ
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$48.1M |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$27.7M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
+$10.7M |
| 4 |
PRXL
Parexel International Corp
PRXL
|
+$10.3M |
| 5 |
CELG
Celgene Corp
CELG
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.9% |
| 2 | Technology | 16.24% |
| 3 | Healthcare | 13.01% |
| 4 | Industrials | 10.83% |
| 5 | Consumer Discretionary | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGC
2676
DELISTED
Energy XXI Gulf Coast, Inc. Common Stock
EGC
| $167K | ﹤0.01% |
29,018
-5,284
| -15% | -$37.2K |
|
|
EGLE
2677
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $166K | ﹤0.01% |
5,286
-981
| -16% | -$30.9K |
|
|
FRE
2678
DELISTED
FREDDIE MAC D/B/A VOTING
FRE
| $166K | ﹤0.01% |
66,008
| – | – |
|
2679
KVH Industries
KVHI
$181M
| $165K | ﹤0.01% |
15,933
-2,745
| -15% | -$30.5K |
|
2680
Standard BioTools
LAB
$351M
| $165K | ﹤0.01% |
27,941
-3,248
| -10% | -$17.8K |
|
2681
Ameresco
AMRC
$1.09B
| $164K | ﹤0.01% |
19,054
-3,600
| -16% | -$29.9K |
|
|
UBFO
2682
DELISTED
United Security Bancshares
UBFO
| $164K | ﹤0.01% |
14,922
-2,327
| -13% | -$23K |
|
|
ATHX
2683
DELISTED
Athersys, Inc. Common Stock
ATHX
| $164K | ﹤0.01% |
3,629
-838
| -19% | -$40.5K |
|
|
BOJA
2684
DELISTED
Bojangles', Inc. Common Stock
BOJA
| $164K | ﹤0.01% |
13,936
-3,948
| -22% | -$49.8K |
|
2685
Lineage Cell Therapeutics
LCTX
$277M
| $163K | ﹤0.01% |
86,641
| – | – |
|
|
RYZ
2686
Ryerson Holding Corp
RYZ
$1.39B
| $163K | ﹤0.01% |
15,669
-2,844
| -15% | -$26.5K |
|
|
HIVE
2687
DELISTED
Aerohive Networks
HIVE
| $163K | ﹤0.01% |
27,879
-4,566
| -14% | -$22K |
|
|
MLNT
2688
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $161K | ﹤0.01% |
+2,037
| New | +$151K |
|
2689
Evolution Petroleum
EPM
$131M
| $159K | ﹤0.01% |
23,226
-4,850
| -17% | -$34.1K |
|
2690
PDS Biotechnology
PDSB
$39.1M
| $159K | ﹤0.01% |
847
-167
| -16% | -$33.6K |
|
2691
Smart Sand
SND
$179M
| $159K | ﹤0.01% |
18,312
-3,907
| -18% | -$30.3K |
|
|
OTIC
2692
DELISTED
Otonomy, Inc.
OTIC
| $159K | ﹤0.01% |
28,661
-5,269
| -16% | -$22.9K |
|
2693
Ooma
OOMA
$589M
| $158K | ﹤0.01% |
13,205
-3,028
| -19% | -$32.2K |
|
2694
Ceco Environmental
CECO
$3.83B
| $156K | ﹤0.01% |
30,430
-5,443
| -15% | -$36.6K |
|
|
COOP
2695
DELISTED
Mr. Cooper
COOP
| $156K | ﹤0.01% |
15,344
-3,049
| -17% | -$29.3K |
|
2696
Lindblad Expeditions
LIND
$1.95B
| $156K | ﹤0.01% |
15,972
-6,846
| -30% | -$71.1K |
|
|
TNAV
2697
DELISTED
Telenav Inc.
TNAV
| $156K | ﹤0.01% |
28,353
-6,013
| -17% | -$33.6K |
|
|
WAAS
2698
DELISTED
AquaVenture Holdings Limited
WAAS
| $156K | ﹤0.01% |
10,033
-2,069
| -17% | -$29.7K |
|
2699
NLI Holdings
NL
$290M
| $155K | ﹤0.01% |
10,880
-791
| -7% | -$10K |
|
|
AGFS
2700
DELISTED
AgroFresh Solutions Inc
AGFS
| $155K | ﹤0.01% |
20,975
-3,927
| -16% | -$24.9K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, RhumbLine Advisers held 2,920 positions worth $49.2B, up 7.1% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2017: portfolio turnover was 3.5%. RhumbLine Advisers opened 16 new positions and exited 85, leaving the 2,920-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 187,382 shares worth $9.83M.
- RhumbLine Advisers added most to Microsoft in Q4 2017, an estimated $23.3M increase.
- RhumbLine Advisers's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.2M.
- RhumbLine Advisers fully exited CR Bard Inc. in Q4 2017, selling an estimated $48.1M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $49.2B portfolio in Q4 2017.
- RhumbLine Advisers opened 16 new positions and closed 85 in Q4 2017.
- RhumbLine Advisers's portfolio value rose 7.1% quarter-over-quarter to $49.2B.
Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.